Katherine A. High
2015
In 2015, Katherine A. High earned a total compensation of $3.8M as President and Chief Scientific Officer at Spark Therapeutics, a 570% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $230,000 |
|---|---|
| Salary | $403,558 |
| Stock Awards | $3,175,603 |
| Other | $17,835 |
| Total | $3,826,996 |
High received $3.2M in stock awards, accounting for 83% of the total pay in 2015.
High also received $230K in non-equity incentive plan, $403.6K in salary and $17.8K in other compensation.
Rankings
In 2015, Katherine A. High's compensation ranked 2,301st out of 13,638 executives tracked by ExecPay. In other words, High earned more than 83.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,301 out of 13,638 | 83rd |
Division Manufacturing | 829 out of 5,190 | 84th |
Major group Chemicals And Allied Products | 297 out of 1,854 | 84th |
Industry group Drugs | 236 out of 1,528 | 85th |
Industry Biological Products, Except Diagnostic Substances | 43 out of 254 | 83rd |
Source: SEC filing on April 21, 2017.
High's colleagues
We found two more compensation records of executives who worked with Katherine A. High at Spark Therapeutics in 2015.